Answers are grounded in this paper and cite their sources.
Background: Initial asthma management often relies on a one-size-fits-all approach; however, the heterogeneity of treatment-naive, uncontrolled asthma remains insufficiently characterized. Specifically, the complex relationships among symptom burden, type 2 (T2) inflammation, and pulmonary function in this population are poorly understood. Objective: We sought to identify distinct clinical phenotypes in treatment-naive adults via multidimensional analysis and evaluate the association between symptom scores and T2 inflammation. Methods: and forced expiratory flow at 25% to 75% of forced vital capacity). Logistic regression assessed the ability of ACQ-5 scores to predict T2-high status (blood eosinophils ≥ 300/μL and fractional exhaled nitric oxide > 50 ppb). ACQ-5 scores showed limited ability to discriminate T2-high status (area under the curve 0.615). Multivariable modeling provided only modest improvement (area under the curve 0.644). Conclusions: In this study population, treatment-naive uncontrolled asthma comprises 3 clinically distinct phenotypes with divergent inflammatory and functional profiles. Symptom burden alone appeared to be a limited predictor of T2-high inflammation. These exploratory findings suggest that incorporating objective biomarkers and functional assessments into initial care may help tailor therapeutic strategies for patients with small airway dysfunction or discordant symptom-inflammation profiles. Further validation in larger cohorts is required.
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: